• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US DELTA CER HEAD 12/14 32MM +1; ARTICULEZE HEAD (12/14 TAPER) : HIP CERAMIC FEMORAL HEADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US DELTA CER HEAD 12/14 32MM +1; ARTICULEZE HEAD (12/14 TAPER) : HIP CERAMIC FEMORAL HEADS Back to Search Results
Model Number 1365-32-310
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Joint Dislocation (2374); Not Applicable (3189)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
The surgeon told me today another case of liner break in his patients.Now we have this new case in which the (b)(6) patient had a liner break causing the prosthesis head to dislocate with just 1 year and 3 months of surgery.The patient will undergo a new surgery next saturday, (b)(6) 2019 and the doctor requests to use in the patient an altrx instead of marathon device.Implantation surgery: (b)(6) 2018; explantation surgery: (b)(6) 2019 (scheduled).
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint # : (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed, and the investigation will be re-opened as necessary.Device history lot : null.Device history batch : null.Device history review : null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DELTA CER HEAD 12/14 32MM +1
Type of Device
ARTICULEZE HEAD (12/14 TAPER) : HIP CERAMIC FEMORAL HEADS
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key9559544
MDR Text Key185356387
Report Number1818910-2020-00937
Device Sequence Number1
Product Code LZO
UDI-Device Identifier10603295033431
UDI-Public10603295033431
Combination Product (y/n)N
PMA/PMN Number
K031803
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2022
Device Model Number1365-32-310
Device Catalogue Number136532310
Device Lot Number8655705
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/16/2019
Initial Date FDA Received01/07/2020
Supplement Dates Manufacturer Received03/09/2020
Supplement Dates FDA Received03/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
PINN CAN BONE SCREW 6.5MMX30MM; PINN CAN BONE SCREW 6.5MMX40MM; PINNACLE SECTOR II CUP 58MM; SUMMIT POR TAPER SZ5 STD OFF
Patient Outcome(s) Required Intervention;
Patient Age39 YR
-
-